We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,105

Why the Healthcare Industry Should Pay Particular Attention to Drug and Alcohol Issues in the Workplace
  • Jackson Lewis PC
  • USA
  • March 21 2018

While all employers struggle with navigating the ever-changing landscape of drug and alcohol issues in the workplace, healthcare employers should pay


CMS re-release of clinical laboratory fee schedule payment rates a reminder to keep eye on updates
  • Conduent
  • USA
  • March 13 2018

For those who price Medicaid professional services, each year can prove to be a guessing game for when the Centers for Medicare & Medicaid Services


340B Update for Hospitals: CMS Publishes FAQs Clarifying Use of Modifiers in Connection with 340B Program Reimbursement Cut on Part B Drugs
  • K&L Gates
  • USA
  • December 18 2017

On December 13, 2017, the Centers for Medicare & Medicaid Services (“CMS”) published subregulatory guidance to answer questions about billing for


CMS Releases 2018 MACRA Final Rule
  • Holland & Knight LLP
  • USA
  • November 10 2017

The Centers for Medicare & Medicaid Services (CMS) on Nov. 2, 2017, posted the CY 2018 Quality Payment Program (QPP) Final Rule. CMS finalized


Washington Healthcare Update - Nov 6, 2017
  • McGuireWoods LLP
  • USA
  • November 6 2017

On Nov. 3, the House passed legislation to renew the Children’s Hospital Insurance Program, 242-174. Only 15 Democrats voted for the proposal. Of


The Opioid Crisis: Declaring a National Emergency and the Effect on Remote Prescribing through Telemedicine
  • McDermott Will & Emery
  • USA
  • October 20 2017

On July 31, 2017, President Donald Trump’s Commission on Combating Drug Addiction and the Opioid Crisis recommended that he declare the opioid


Giving Telemedicine More Room to Breathe: Recent and Pending State and Federal Actions in the World of Online Prescribing
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • July 10 2017

On October 18, 2008, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the “Haight Act”) came into law as the federal government’s


Ohio Attorney General Sues Pharmaceutical Companies Over Opioid Marketing - Yet Another Sign of Government Focus on Recovering Financial Cost of Opioid Epidemic
  • Pietragallo Gordon Alfano Bosick & Raspanti LLP
  • USA
  • June 9 2017

Last week, Ohio Attorney General Mike DeWine filed a lawsuit against multiple pharmaceutical companies, including Purdue, Teva, Johnson & Johnson


New FDA Commissioner Hits the Ground Running
  • Foley & Lardner LLP
  • USA
  • May 30 2017

Fresh off his noticeably smooth confirmation, the new Commissioner of Food and Drugs, Dr. Scott Gottlieb, appeared before Congress last Thursday and


Third Circuit Affirms Dismissal of FCA Suit Against Genentech Based on Supreme Court’s Materiality Standard
  • McDermott Will & Emery
  • USA
  • May 10 2017

On May 1, 2017, the US Court of Appeals for the Third Circuit affirmed the dismissal of United States ex rel. Petratos, et al. v. Genentech, Inc., et